NL-OMON22399已完成不适用
A Phase I/II study of clofarabine in combination with cytarabine and liposomal daunorubicin in children with relapsed/refractory pediatric AML.
Erasmus MC, Rotterdam, The Netherlands0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. 2nd relapse of AML;
- •2. Refractory AML in 1st relapse (defined as ≥ 20% blasts in the bone marrow after the 1st course of re-induction therapy according to the AML 2001/01 protocol);
排除标准
- •1. Isolated extramedullary relapse, including isolated CNS-relapse;
- •2. Symptomatic CNS leukemia in case of combined relapse;
研究者
相似试验
进行中（未招募）
不适用
A Phase I/II study of clofarabine in combination with cytarabine and liposomal daunorubicin in children with relapsed/refractory pediatric AML - CLARA-DNXEUCTR2009-009457-13-ATErasmus MC28
进行中（未招募）
1 期
This study aims to investigate the safety and efficacy of clofarabine, given in combination with cytarabine and liposomal daunorubicin, in the treatment of children with relapsed/refractory acute myeloid leukemia (AML)EUCTR2009-009457-13-DEErasmus MC34
进行中（未招募）
不适用
This study aims to investigate the safety and efficacy of clofarabine, given in combination with cytarabine and liposomal daunorubicin, in the treatment of children with relapsed/refractory acute myeloid leukemia (AML)Relapsed/refractory acute myeloid leukemiaMedDRA version: 14.0Level: LLTClassification code 10066638Term: Acute myeloid leukemia progressionSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.0Level: LLTClassification code 10060558Term: Acute myeloid leukemia recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-009457-13-NLErasmus MC28
进行中（未招募）
不适用
A Phase I/II study of clofarabine in combination with cytarabine and liposomal daunorubicin in children with relapsed/refractory pediatric AML - CLARA-DNXRelapsed/refractory acute myeloid leukemiaMedDRA version: 12.0Level: LLTClassification code 10060558Term: Acute myeloid leukemia recurrentMedDRA version: 12.0Level: LLTClassification code 10066638Term: Acute myeloid leukemia progressionEUCTR2009-009457-13-CZErasmus MC28
进行中（未招募）
1 期
A Phase I/II study of clofarabine in combination with cytarabine and liposomal daunorubicin in children with relapsed/refractory pediatric AML - CLARA-DNXRelapsed/refractory acute myeloid leukemiaMedDRA version: 9.1Level: LLTClassification code 10060558Term: Acute myeloid leukemia recurrentMedDRA version: 9.1Level: LLTClassification code 10066638Term: Acute myeloid leukemia progressionEUCTR2009-009457-13-FRHospices Civils de Lyon34